Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
KLF11 protects against abdominal aortic aneurysm through inhibition of endothelial cell dysfunction
Guizhen Zhao, Ziyi Chang, Yang Zhao, Yanhong Guo, Haocheng Lu, Wenying Liang, Oren Rom, Huilun Wang, Jinjian Sun, Tianqing Zhu, Yanbo Fan, Lin Chang, Bo Yang, Minerva T. Garcia-Barrio, Y. Eugene Chen, Jifeng Zhang
Guizhen Zhao, Ziyi Chang, Yang Zhao, Yanhong Guo, Haocheng Lu, Wenying Liang, Oren Rom, Huilun Wang, Jinjian Sun, Tianqing Zhu, Yanbo Fan, Lin Chang, Bo Yang, Minerva T. Garcia-Barrio, Y. Eugene Chen, Jifeng Zhang
View: Text | PDF
Research Article Vascular biology

KLF11 protects against abdominal aortic aneurysm through inhibition of endothelial cell dysfunction

  • Text
  • PDF
Abstract

Abdominal aortic aneurysm (AAA) is a life-threatening degenerative vascular disease. Endothelial cell (EC) dysfunction is implicated in AAA. Our group recently demonstrated that Krüppel-like factor 11 (KLF11) plays an essential role in maintaining vascular homeostasis, at least partially through inhibition of EC inflammatory activation. However, the functions of endothelial KLF11 in AAA remain unknown. Here we found that endothelial KLF11 expression was reduced in the ECs from human aneurysms and was time dependently decreased in the aneurysmal endothelium from both elastase- and Pcsk9/AngII-induced AAA mouse models. KLF11 deficiency in ECs markedly aggravated AAA formation, whereas EC-selective KLF11 overexpression markedly inhibited AAA formation. Mechanistically, KLF11 not only inhibited the EC inflammatory response but also diminished MMP9 expression and activity and reduced NADPH oxidase 2–mediated production of reactive oxygen species in ECs. In addition, KLF11-deficient ECs induced smooth muscle cell dedifferentiation and apoptosis. Overall, we established endothelial KLF11 as a potentially novel factor protecting against AAA and a potential target for intervention in aortic aneurysms.

Authors

Guizhen Zhao, Ziyi Chang, Yang Zhao, Yanhong Guo, Haocheng Lu, Wenying Liang, Oren Rom, Huilun Wang, Jinjian Sun, Tianqing Zhu, Yanbo Fan, Lin Chang, Bo Yang, Minerva T. Garcia-Barrio, Y. Eugene Chen, Jifeng Zhang

×

Figure 2

Endothelial cell–specific KLF11 depletion aggravates Pcsk9/AngII-induced AAA.

Options: View larger image (or click on image) Download as PowerPoint
Endothelial cell–specific KLF11 depletion aggravates Pcsk9/AngII-induced...
The Pcsk9/AngII-induced AAA model was performed on 8-week-old males with Klf11ECKO (n = 15) and their littermate Klf11fl/fl (n = 13) mice. (A) Schematics of Pcsk9/AngII-induced AAA model. (B) Representative morphology of aortas from AngII-infused Klf11fl/fl and Klf11ECKO mice. (C) Incidence of AAA. (D) Maximal diameters of suprarenal abdominal aortas (SAAs) from AngII-infused Klf11fl/fl (n = 12) and Klf11ECKO (n = 14) mice. (E) Representative Verhoeff-Van Gieson (VVG) staining and quantification of elastin degradation in SAAs from AngII-infused Klf11fl/fl (n = 12) and Klf11ECKO (n = 14) mice. Scale bar: 50 μm. (F) Representative immunofluorescence staining and quantification of leukocyte (CD45+) and macrophage (Mac2+) infiltration in the aortic wall of SAAs from AngII-infused Klf11fl/fl (n = 12) and Klf11ECKO (n = 14) mice. Scale bar: 20 μm. (G) ELISA analysis of MCP-1 and IL-6 in the plasma from AngII-infused Klf11fl/fl (n = 12) and Klf11ECKO (n = 14) mice. (H) Representative TUNEL staining (green) and quantification of apoptotic cells in the media of SAAs from AngII-infused Klf11fl/fl (n = 12) and Klf11ECKO (n = 14) mice. Scale bar: 20 μm. (I) Representative DHE staining (red) and quantification of ROS production in the aortic wall of SAAs from AngII-infused Klf11fl/fl (n = 5) and Klf11ECKO (n = 6). Scale bar: 20 μm. Data are presented as mean ± SEM. χ2 test (C), Student’s 2-tailed t test (D, G, and I), Mann-Whitney U test (E, F, and H).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts